BioSpace News Archive

Over the past 25 years, SiliCycle has developed, manufactured and marketed extraction and purification products for the pharmaceutical industry in more than 85 countries.

Dr. Summers to help guide Cerevance’s Drug Discovery and Development Efforts

Alterations of the MET signaling pathway are present in 3-5% of non-small cell lung cancer patients and correlate with poor prognosis

Sareum Holdings plc (AIM: SAR), the specialist small molecule drug development business, notes that Sierra Oncology (the licence holder for SRA737) held an analyst and investor event today featuring distinguished oncologists Professor Johann de Bono and Dr Rebecca Kristeleit, to discuss clinical findings and possible next steps for SRA737, its oral, highly selective Chk1 inhibitor

Clinical Genomics today presented research detailing breakthrough methods of colorectal cancer recurrence monitoring at the American Society of Clinical Oncology (ASCO) annual meeting in the McCormick Place Convention Center, Chicago.

A Pittsburgh-based start-up company, Rehat LLC, was selected for a competitive $1.33M award by Medical Technology Consortium Enterprise to pilot a novel telehealth platform treating the unmet sleep healthcare needs of Service Members.

Doctor Evidence, a global health technology and healthcare research consulting company, continues to breakthrough artificial intelligence hurdles with the ability to auto-identify research studies that are based on real-world evidence.

Maxar Technologies announced that it has been awarded a study contract with the National Reconnaissance Office that will enable the U.S. Government to gain a greater understanding of Maxar’s current and future commercial imagery capabilities.

Commitment to high-quality standards and rigorous process assessment results in 100% score

Aesthetic Management Partners announced that it will be the exclusive distributor in the U.S. for Scarlet SRF, a revolutionary short radio frequency skin tightening treatment.